Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Featured News
Scientists Decode Diet From Stool DNA – No Questions Asked
ISB’s Gibbons Lab developed a breakthrough method that analyzes food-derived DNA in fecal metagenomes, allowing for data-driven diet tracking without the need for burdensome questionnaires.
More News
Dr. Sean Gibbons joins ISB faculty as WRF Distinguished Investigator
Dr. Sean Gibbons has joined ISB as our newest faculty member. Gibbons’ new position brings a number of changes, including relocating to the Pacific Northwest from the Northeast. Read on for a Q&A with Gibbons that sheds light on his research career to date, areas of study and even a hidden talent.
The Future of Health: Presentations from ISB’s 17th Annual International Symposium
At our 17th Annual International Symposium, focusing on the Future of Health, we welcomed speakers who are experts in diverse areas including environmental and occupational health, infectious disease transmission and forecast, drug and vaccine development, communicable disease dynamics, and beyond. Here is a video roundup of presentations from our two-day event.
ISB’s Dr. Eliza Peterson Earns TB Junior Investigator Award
Dr. Eliza Peterson, a senior research scientist who studies tuberculosis (TB) in the Institute for Systems Biology’s Baliga Lab, has been recognized by the University of Washington’s Tuberculosis Research and Training Center with a TB Junior Investigator Award.
ISB’s Computational Teams Play Central Role in Completion of TCGA’s PanCancer Atlas Initiative
ISB’s computational and bioinformatics teams played a central role in the completion of the PanCancer Atlas Initiative, the final phase of TCGA. The culmination of this work is being published in 27 papers this week across the Cell Press research journals, including “The Immune Landscape of Cancer” in Immunity.
Cancer Research Institute, ISB, Sage Bionetworks Unveil Comprehensive Immunotherapy Tool
Three organizations on the forefront of cancer immunotherapy, systems biology and bioinformatics announced the release of the Cancer Research Institute iAtlas, a comprehensive web-based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment.
Jumping In Head First: Dr. Jim Heath Takes Helm of ISB, Looks Toward the Future
Jim Heath took over as president of Institute for Systems Biology on January 1, 2018. To fully appreciate Heath’s relationship with ISB, you have to go back to its early days – shortly after the research organization was founded in 2000.